The Institute for Glycomics has been delivering major translational outcomes from its research in recent months, which will be celebrated during Glycomics Week. Glycomics Week highlights the Institute’s growing significant research successes. The Institute recently announced partnerships with Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc., for a new Strep A vaccine that has the enormous potential to help millions, […]
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
Two researchers from Griffith’s Institute for Glycomics have been awarded Fellowships with the American Academy of Microbiology for their contributions to the scientific field. Professor Michael Jennings and Professor Suresh Mahalingam both have outstanding records of scientific achievement and exceptional contributions to the advancement of microbiology through a peer-review process. Recently Professor Jennings made a […]